CanSino Biologics (Germany) Price on October 1, 2024

CJH Stock   3.36  0.06  1.82%   
If you're considering investing in CanSino Stock, it is important to understand the factors that can impact its price. As of today, the current price of CanSino Biologics stands at 3.36, as last reported on the 28th of November, with the highest price reaching 3.36 and the lowest price hitting 3.36 during the day. CanSino Biologics appears to be very risky, given 3 months investment horizon. CanSino Biologics secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16% return per unit of risk over the last 3 months. By analyzing CanSino Biologics' technical indicators, you can evaluate if the expected return of 0.86% is justified by implied risk. Please makes use of CanSino Biologics' Downside Deviation of 5.23, risk adjusted performance of 0.1522, and Mean Deviation of 3.71 to double-check if our risk estimates are consistent with your expectations.
  
CanSino Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1607

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsCJH
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.35
  actual daily
47
53% of assets are more volatile

Expected Return

 0.86
  actual daily
17
83% of assets have higher returns

Risk-Adjusted Return

 0.16
  actual daily
12
88% of assets perform better
Based on monthly moving average CanSino Biologics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CanSino Biologics by adding it to a well-diversified portfolio.

CanSino Biologics Valuation on October 1, 2024

It is possible to determine the worth of CanSino Biologics on a given historical date. On October 1, 2024 CanSino was worth 3.2 at the beginning of the trading date compared to the closed value of 3.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CanSino Biologics stock. Still, in general, we apply an absolute valuation method to find CanSino Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CanSino Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CanSino Biologics' related companies.
 Open High Low Close Volume
  3.20    3.20    3.20    3.20    1.00  
10/01/2024
  3.20    3.20    3.20    3.20    1.00  
  3.24    3.24    3.24    3.24    1.00  
Backtest CanSino Biologics  |  CanSino Biologics History  |  CanSino Biologics Valuation   PreviousNext  
Open Value
3.2
3.2
Closing Value
19.25
Upside

CanSino Biologics Trading Date Momentum on October 1, 2024

On October 02 2024 CanSino Biologics was traded for  3.24  at the closing time. The highest price during the trading period was 3.24  and the lowest recorded bid was listed for  3.24 . There was no trading activity during the period 1.0. Lack of trading volume on October 2, 2024 contributed to the next trading day price appreciation. The overall trading delta to the next closing price was 1.25% . The overall trading delta to the current price is 6.88% .

CanSino Biologics Fundamentals Correlations and Trends

By evaluating CanSino Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CanSino Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CanSino financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About CanSino Biologics Stock history

CanSino Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CanSino is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CanSino Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CanSino Biologics stock prices may prove useful in developing a viable investing in CanSino Biologics

CanSino Biologics Stock Technical Analysis

CanSino Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CanSino Biologics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CanSino Biologics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

CanSino Biologics Period Price Range

Low
November 28, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

CanSino Biologics cannot be verified against its exchange. Please verify the symbol is currently traded on Stuttgart Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

CanSino Biologics November 28, 2024 Market Strength

Market strength indicators help investors to evaluate how CanSino Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CanSino Biologics shares will generate the highest return on investment. By undertsting and applying CanSino Biologics stock market strength indicators, traders can identify CanSino Biologics entry and exit signals to maximize returns

CanSino Biologics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for CanSino Biologics' price direction in advance. Along with the technical and fundamental analysis of CanSino Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CanSino to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for CanSino Stock Analysis

When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.